|
"shih jin yuan"的相关文件
显示项目 81-105 / 208 (共9页)
<< < 1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T06:47:44Z |
Cytologically proven meningeal carcinomatosis in patients with lung cancer: Clinical observation of 34 cases
|
Chuang, T.-Y. and Yu, C.-J. and Shih, J.-Y. and Yang, P.-C. and Kuo, S.-H.; 莊子儀;余忠仁;施金元;楊泮池;郭壽雄; CHUANG, TZU-YI;YU, CHONG-JEN;SHIH, JIN- YUAN;YANG, PAN-CHYR;KUO, SOW-HSONG;SHIH, JIN-YUAN; Chong-Jen Yu; JIN-YUAN SHIH; CHUANG, TZU-YI; Yu, Chong-Jen; SHIH, JIN- YUAN; YANG, PAN-CHYR; KUO, SOW-HSONG; SHIH, JIN-YUAN |
| 國立臺灣大學 |
2016 |
EGFR mutation and lobar location of lung adenocarcinoma
|
Tseng, Chien-Hua; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Ho, Chao-Chi; Hsia, Te-Chun; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Liu, Chien-Ming; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, Tsung-Ying; Chang, Gee-Chen; 俞松良; 蘇剛毅; 楊泮池; 廖唯昱; 陳冠宇; 余忠仁; 何肇基; 施金元 |
| 國立臺灣大學 |
2016 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu, Shang-Gin; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Yih-Leong; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, James Chih-Hsin; Wen, Yueh-Feng; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2016 |
Efficacy of of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations
|
Chen, Yen-Fu; Hsieh, Min-Shu; Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 施金元 |
| 國立臺灣大學 |
2016 |
The Role of PIK3CA Mutations among Lung Adenocarcinoma Patients with Primary and Acquired Resistance to EGFR Tyrosine Kinase Inhibition
|
Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; Yang, Pan-Chyr; Shih, Jin-Yuan; 張逸良; 楊泮池; 余忠仁; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2016 |
Association of BIM Deletion Polymorphism With Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Patients With Lung Adenocarcinoma
|
Wu, Shang-Gin; Liu, Yi-Nan; Yu, Chong-Jen; Yang, Pan-Chyr; Shih, Jin-Yuan; 余忠仁; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2016 |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen, Li-Yang; Molina-Vila, Miguel A.; Ruan, Sheng-Yuan; Su, Kang-Yi; Liao, Wei-Yu; Yu, Kai-Lun; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; Rosell, Rafael; Yang, Pan-Chyr; 楊志新; 蘇剛毅; 廖唯昱; 余忠仁; 何肇基; 阮聖元; 施金元 |
| 國立臺灣大學 |
2016 |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non-Small-Cell Lung Cancer: Analysis and Literature Review
|
Lin, Yen-Ting; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 林奕廷; 林怡岑; 施金元 |
| 大葉大學 |
2015-04 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer.
|
Liu, Yi-Nan;Chang, Tzu-Hua;Tsai, Meng-Feng;Wu, Shang-Gin;Tsai, Tzu-Hsiu;Chen, Hsuan-Yu;Yu, Sung-Liang;Yang, James Chih-Hsin;Shih, Jin-Yuan |
| 國立臺灣大學 |
2015 |
DUSP1 Expression Induced by HDAC1 Inhibition Mediates Gefitinib Sensitivity in Non-Small Cell Lung Cancers
|
Lin, Yun-Chieh; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow; 張逸良; 施金元; 陳青周 |
| 國立臺灣大學 |
2015 |
Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer
|
Wei, Tzu-Tang; Lin, Yu-Chin; Lin, Pei-Hua; Shih, Jin-Yuan; Chou, Chia-Wei; Huang, Wei-Jan; Yang, Yu-Chih; Hsiao, Pei-Wen; Chen, Ching-Chow; 施金元; 陳青周 |
| 國立臺灣大學 |
2015 |
Identification of Five Driver Gene Mutations in Patients with Treatment-Naive Lung Adenocarcinoma in Taiwan
|
Hsu, Kuo-Hsuan; Ho, Chao-Chi; Hsia, Te-Chun; Tseng, Jeng-Sen; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Yang, Tsung-Ying; Chen, Kun-Chieh; Ooi, Hean; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Chang, Gee-Chen; 俞松良; 蘇剛毅; 楊泮池; 廖唯昱; 陳冠宇; 余忠仁; 何肇基; 施金元 |
| 國立臺灣大學 |
2015 |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu; Wu, Shang-Gin; Hsieh, Min-Shu; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 謝明書; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis
|
Hsu, Chia-Lin; Chen, Jen-Hau; Chen, Kuan-Yu; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; 楊志新; 楊泮池; 許嘉林; 陳冠宇; 余忠仁; 陳人豪; 施金元 |
| 國立臺灣大學 |
2015 |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Tsai, Meng-Feng; Chang, Tzu-Hua; Wu, Shang-Gin; Yang, Hsiao-Yin; Hsu, Yi-Chiung; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊泮池; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2015 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Liu, Yi-Nan; Chang, Tzu-Hua; Tsai, Meng-Feng; Wu, Shang-Gin; Tsai, Tzu-Hsiu; Chen, Hsuan-Yu; Yu, Sung-Liang; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 俞松良; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
Maintenance therapy with gefitinib (G)/pemetrexed (P) versus P alone after induction therapy with P/platinum for metastatic lung adenocarcinoma (MLADC) harboring no sensitizing epidermal growth factor receptor mutation (sEGFRm): A phase II multicenter randomized open-label study (GENIUS trial).
|
Tsai, Chun-Ming; Lai, Chun-Liang; Chiu, Chao-Hua; Hsia, Te-Chun; Chen, Chen-Hsin; Chang, Gee-Chen; Shih, Jin-Yuan; Ho, Ching-Liang; Chen, Yuh-Min; Yang, James Chih-Hsin; 楊志新; 施金元 |
| 國立臺灣大學 |
2015 |
Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis.
|
Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 余忠仁; 何肇基; 施金元; 李日翔 |
| 國立臺灣大學 |
2015 |
The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases
|
Chiang, Yun; Yang, James Chih-Hsin; Hsu, Feng-Ming; Chen, Yu-Hsuan; Shih, Jin-Yuan; Lin, Zhong-Zhe; Lan, Keng-Hsueh; Cheng, Ann-Lii; Kuo, Sung-Hsin; 楊志新; 郭頌鑫; 鄭安理; 陳育瑄; 藍耿學; 施金元; 許峰銘 |
| 國立臺灣大學 |
2015 |
Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategy
|
Liao, Bin-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 施金元 |
| 國立臺灣大學 |
2015 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
Liao, Bin-Chi; Lee, Jih-Hsiang; Lin, Chia-Chi; Chen, Ya-Fang; Chang, Chin-Hao; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 陳雅芳; 余忠仁; 何肇基; 施金元; 李日翔; 張晉豪 |
| 國立臺灣大學 |
2015 |
Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene
|
Wu, Hsu; Shih, Jin-Yuan; Yang, James Chih-Hsin; 楊志新; 施金元 |
| 國立臺灣大學 |
2015 |
Maintenance with Gefitinib/Pemetrexed (G/P) or P After Induction P/Platinum for Stage IV Lung Adenocarcinoma with No Sensitizing EGFR Mutation
|
Tsai, Chun-Ming; Lai, Chun-Liang; Chiu, Chao-Hua; Hsia, Te-Chun; Chen, Chen-Hsin; Chang, Gee-Chen; Shih, Jin-Yuan; Ho, Ching-Liang; Chen, Yuh-Min; Yang, James Chih-Hsin; 楊志新; 施金元; 陳珍信 |
| 國立臺灣大學 |
2014 |
Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: identification of a rare CD74-NRG1 translocation case
|
Gow, Chien-Hung; Wu, Shang-Gin; Chang, Yih-Leong; Shih, Jin-Yuan; 張逸良; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2014 |
Clinicopathologic Characteristics and Prognostic Significance of EGFR and p53 Mutations in Surgically Resected Lung Adenocarcinomas <= 2 cm in Maximal Dimension
|
Lin, Mong-Wei; Wu, Chen-Tu; Shih, Jin-Yuan; Chang, Yih-Leong; Yang, Pan-Chyr; 吳振都; 張逸良; 楊泮池; 林孟暐; 施金元 |
显示项目 81-105 / 208 (共9页)
<< < 1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
|
